Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Finasteride, used for the treatment of prostate cancer, is generic equivalent of Merck’s Proscar
Subscribe to our email newsletter
Actavis has launched Finasteride in France, just one day before the patent expired. The distribution of the product has already been initiated.
Finasteride Actavis was launched by the company under its brand name, and at the same time, by various Medis clients.
Finasteride, used for the treatment of prostate cancer, is the generic equivalent of Merck’s Proscar. Finasteride Actavis is available in tablets of 5mg in France.
Finasteride Actavis was developed by Actavis in Iceland, and has already been launched by Actavis and its third-party clients in other European countries and in the US.
Actavis is a Iceland-based company focused on the development, manufacture, and sale of generic pharmaceuticals. It has over 300 products, market launches and product pipelines.